KEGG   DRUG: Vonicog alfaHelp
Entry
D08681                      Drug                                   

Name
Vonicog alfa (USAN);
Vonicog alfa (genetical recombination) (JAN);
Von willebrand factor;
Wilfactin (TN);
Vonvendi (TN)
Formula
C9712H15373N2737O3032S210
Exact mass
225574.4238
Mol weight
225723.1487
Class
Cardiovascular agent
 DG02016  Hemostatics
  DG02013  Blood coagulation factor
  DG02014  Blood coagulation accelerant
   DG02013  Blood coagulation factor
Remark
Therapeutic category: 6349
ATC code: B02BD10
Product: D08681<JP>
Efficacy
Anticoagulant, Hemostatic, Replenisher (von Willebrand factor)
Comment
recombinant von Willebrand factor (vWF) [HSA:7450] [KO:K03900]
Prophylactic treatment of bleeding episodes and Von Willebrand disease
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD10 von Willebrand factor
      D08681  Vonicog alfa (USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6349  Others
     D08681  Vonicog alfa (USAN); Vonicog alfa (genetical recombination) (JAN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D08681
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D08681
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D08681
BRITE hierarchy
Other DBs
CAS: 109319-16-6
PubChem: 96025364
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system